IP Infusion's OcNOS® provides a feature-rich upgrade platform for French internet and managed service provider
SANTA CLARA, Calif., March 27, 2024 – IP Infusion, the market leader in carrier-grade networking software systems, announced today that Prosoluce, an internet and managed service provider based in France, has chosen to upgrade its backbone network with IP Infusion software and 100G open networking hardware from Edgecore Networks. Open networking systems integrator Pine Networks, which specializes in open, disaggregated, and virtualized solutions, guided Prosoluce through this journey of backbone upgrade.
Prosoluce is a regional internet service provider, cloud provider, and managed services provider. Responding to growing demand and addressing upgrade limitations with its 10G backbone network, Prosoluce は、マルチサイト・マルチテナントサービスの提供を可能にする最先端の EVPN-VXLAN 技術に基づく新しい IP バックボーンの導入を決定した。 After evaluating a competitive field of traditional vendor solutions and refurbished options, disaggregation with IP Infusion came as the best offering. Support from IP Infusion and Pine Networks was decisive in this evaluation process as Prosoluce refined its expectations.
Choosing an upgrade to its existing backbone posed specific interoperating challenges. The new solution required compatibility with Prosoluce's existing networking vendors, which at the time consisted of Alcatel Lucent, Huawei, MikroTik, and Ubiquiti equipment.
"Prosoluce's upgrade to open networking solved several problems at once," said Gaël Hermet, Directeur Général for Prosoluce. "Together with the benefits of a competitive technology and supported interoperability, we valued Pine Networks' recommendation for open networking to avoid single traditional vendor lock-in. IP Infusion software allowed for increased compatibility and performance while lowering costs."
"The benefits of open networking become clear as more organizations look into the Total Cost of Ownership of their network infrastructure," said Hadi Choueiry, General Manager for Pine Networks. "Perhaps more important than cost, open networking solutions provide our customers the flexibility and openness they need."
"With the support of partners and customers such as Pine Networks and Prosoluce, IP Infusion is working to be the open networking software vendor alternative to the networking industry," said Atsushi Ogata, President and CEO of IP Infusion. "Commercial application, an industry-leading price, and robust support are hallmarks of IP Infusion products."
IP Infusion について
IP Infusion manufactures open network software and solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion is a market leader in Network Operating Systems. Our flagship software platform OcNOS® allows network operators to disaggregate their networks, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.
-end-
Media Contact:
Katherine Verducci
1903 PR
kverducci@1903pr.com
408.429.5779
IP Infusion について
IP Infusion はオープンネットワーキングソフトウェアの主要プロバイダーであり、サービスプロバイダー、データセンター、AI ファブリックネットワーク向けのキャリアグレードネットワーク OS である OcNOS を提供しています。1999 年以来のネットワーク技術の知見と世界 600+ のオペレーターでの実績により、Edgecore Networks、UfiSpace、Celestica などのパートナーによる検証済みオープンハードウェア上で、オープンかつマルチベンダーで、コスト効率が高く柔軟なネットワークインフラを実現します。IP Infusion はACCESS CO., LTD.（東京証券取引所: 4813）の完全子会社です。
メディア窓口
For press inquiries, analyst briefings, or media materials, please チームへお問い合わせ or email pr@ipinfusion.com.
将来見通しに関する記述
本リリースには、IP Infusion の製品、技術および計画に関する将来見通しの記述が含まれる場合があります。将来見通しに関する記述は公表日時点で入手可能な情報に基づいており、リスクと不確実性を伴います。実際の結果は異なる可能性があります。製品計画、機能、リリース時期および提供状況は予告なく変更されることがあり、確約、約束または法的義務を構成するものではありません。IP Infusion は将来見通しに関する記述を更新する義務を負いません。